LIVE · UPDATED DAILY
UPCOMING · ESTIMATED✓ VERIFIEDPublished Oct 26, 2026

EyePoint US Inc. cuts 105 Massachusetts jobs after failed clinical trial

SOURCEOFFICIAL FILINGMassachusetts Executive Office of Labor and Workforce Development· filed October 20, 2026View the filing ↗

EMPLOYEES AFFECTED
105
PLANNED DATE
Dec 31, 2026
CONFIRMED IN SOURCE

What we know

Location: Massachusetts, USA.

A WARN notice for this layoff is recorded on October 20, 2026.

Disclosed through an official WARN filing with the MA state workforce agency.

Summary

EyePoint US Inc. eliminated 105 jobs in Massachusetts after a clinical trial failure led the company to reduce staff. The cuts affect the company's Massachusetts workforce and come as the company reassesses its clinical development plans following the unsuccessful trial. Company statements cited the trial outcome as the primary reason for the layoffs and the need to realign resources. The reductions are part of an immediate workforce action tied directly to the program setback and its impact on EyePoint's operations.

EyePoint US Inc. disclosed this layoff in an official WARN (Worker Adjustment and Retraining Notification) notice recorded by the MA state workforce agency on October 20, 2026. The notice covers 105 employees in Northbridge, Watertown, MA, with the layoff effective December 31, 2026.

Comments (0)

Anonymous by default. Be kind — people reading this may be going through it right now.

No comments yet. Be the first to share your thoughts.

SOURCE
Official WARN notice
View state filing ↗
⚠

Estimated figure based on a WARN filing. Not yet confirmed by EyePoint US Inc..

E
EyePoint US Inc.
1
EVENTS TRACKED
105
JOBS IN WARN FILINGS
View company profile

Affected by this?

Share your story anonymously — it helps others reading this feel less alone.

Share your story →
CREATED OCT 25, 2026LAST UPDATED OCT 27, 2026